Search
for

    Learn

    5 / 6 results

    Research

    5 / 1000+ results

      research Research Progress in Chronic Autoimmune Urticaria

      2 citations , November 2019 in “International Journal of Dermatology and Venereology”
      The document discussed chronic autoimmune urticaria (CAU), a subtype of chronic spontaneous urticaria characterized by histamine-releasing IgG autoantibodies. It highlighted the role of the oncostatin M receptor (OSMR) gene in CAU pathogenesis, where silencing the OSMR gene reduced inflammation by inhibiting the JAK/STAT3 signaling pathway. Psychological stress was found to exacerbate CAU by affecting the HPA axis and increasing pro-inflammatory cytokines like IL-6 and IL-18. Diagnosis involved bioassays and immunoassays for specific autoantibodies. Omalizumab, an anti-IgE therapy, was effective for antihistamine-resistant CAU by reducing IgE levels and mast cell activation. The document emphasized the need for immunosuppressive agents, such as low-dose cyclosporine, azathioprine, and sulfasalazine, due to CAU's autoimmune nature. Cyclosporine had T-cell-mediated action but potential side effects, azathioprine showed lasting symptom suppression, and sulfasalazine was safe but required careful monitoring. Improved diagnostic methods and treatment optimization were needed due to CAU's complexity.
      Main Plenary Sessions: Summaries of Papers

      research Main Plenary Sessions: Summaries of Papers

      June 2008 in “British Journal of Dermatology”
      UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

    Community Join

    5 / 1000+ results

      community Shedding and thinning won’t stop on Nuclear protocol

      in Treatment  22 upvotes 2 years ago
      The user is using a combination of hair loss treatments including dutasteride, minoxidil, RU58841, low-level laser therapy, ketokonozole, supplements, Viviscal, Nutrafol, microneedling, PRP, and scalp Botox injections, but is still experiencing hair shedding and thinning. Despite being on this regimen for two years, the user's hair condition is worsening, and they are seeking advice on what else they can do.

      community Having androgen receptor density and sensitivity at wrong f*ing place

      in Satire  7 upvotes 1 year ago
      The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

      community Is regrowth on an androgen receptor blocker possible?

      in Chat  11 upvotes 1 year ago
      RU and Pyri block androgen receptors to prevent hair loss but may also hinder hair regrowth since they prevent testosterone, which can stimulate hair growth, from binding to these receptors. The user is questioning if this understanding is correct.

      community [29 M] 7 month pyrilutamide update.

      in Progress Pictures  125 upvotes 9 months ago
      A 29-year-old male experienced hair regrowth using minoxidil 5% foam and KX826 after stopping finasteride due to side effects. He applies both treatments once daily and reports no side effects from the current regimen.